PPP2CA and prostate cancer: In prostate cancer, PPP2CA downregulation is linked to castration resistance and the activation of epithelial-mesenchymal transition (EMT), contributing to a more invasive tumor phenotype, restoration of PPP2CA activity can reverse EMT, significantly suppressing tumor growth and metastasis [11].